Showcases Stock ranks

Merck & Co. Inc. (MRK)
79.83 0.4 (0.5%) 02-21 16:01
Open: 79.18 Pre. Close: 79.43
High: 80.03 Low: 79.15
Volume: 7,386,114 Market Cap: 207588M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 80.134 - 80.458 80.458 - 80.766
Low: 78.335 - 78.698 78.698 - 79.045
Close: 79.253 - 79.818 79.818 - 80.357
Stock Technical Analysis
Target: Six months: 93.59
One year: 109.32
Support: Support1: 75.14
Support2: 72.05
Resistance: Resistance1: 80.13
Resistance2: 93.59
Pivot: 77.88
Moving Averages: MA(5): 79.45
MA(20): 76.69
MA(100): 74.64
MA(250): 66.71
MACD: MACD(12,26): 1.24
Signal(12,26,9): 0.91
%K %D: %K(14,3): 91.33
%D(3): 91.59
RSI: RSI(14): 65.87
52-Week: High: 80.19
Low: 52.83
Change(%): 46.3
Average Vol(K): 3-Month: 1323738
10-Days: 984914
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

MRK has closed below upper band by 17.0%. Bollinger Bands are 13.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Immune Design Corp.

Immune Design (IMDZ) Alert: Johnson Fistel Investigates Proposed Sale of Immune Design Corp.; Are Immune Design Shareholders Getting a Fair Deal?

U.S. healthcare spending to rise 5.5% per annum over next decade

Merck to acquire Immune Design for $300M

Merck to Acquire Immune Design

Storm Clouds Brewing For Big Pharma

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2600.38
Shares Float (M) 2597.36
% Held by Insiders
% Held by Institutions 115.60
Shares Short (K) 34557
Shares Short Prior Month (K)
Stock Financials
EPS 4.340
EPS Est. Current Year 3.870
EPS Est. Next Year 4.160
EPS Est. Next Quarter 0.960
Forward EPS 4.551
Book Value (p.s.) 6.300
PEG Ratio 1.78
Profit Margin 14.75
Operating Margin 23.51
Return on Assets (ttm) 7.4
Return on Equity (ttm) 18.9
Qtrly Rev. Growth 5.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
P/E 18.39
P/E Growth Ratio 0.01
P/BV 12.67
P/S 13144902656.00
Dividend Yield 0.03
Dividends & Splits
Dividend 2.757
Dividend Pay Date 2019-04-05
Ex-Dividend Date 2019-03-14
Forward Dividend 2.200
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator